GLP 1

Continuous glucose monitors used to be diabetes-only tech.

GLP-1 medications drive fat loss through reduced food intake. They don’t replace cardiovascular fitness. The SELECT trial (Lincoff et al.

Calibrate and TrimRx draw very different reviews because they sell very different products. Calibrate is a year-long coaching-heavy program.

Introduction CagriSema is the cagrilintide 2.4 mg + semaglutide 2.4 mg fixed-dose combination that posted 22.7% mean weight loss in REDEFINE 1 (Novo Nordisk,…

Introduction CagriSema is the fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, both peptide drugs, both unstable at room temperature for long…

Introduction CagriSema’s side effect profile combines the well-known GLP-1 class effects from semaglutide with additional amylin-related effects from cagrilintide. The REDEFINE 1 and 2…

CagriSema is Novo Nordisk’s investigational weight management drug that combines two hormones in a single weekly injection.

CagriSema is the fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg developed by Novo Nordisk.

Introduction CagriSema is the fixed-dose combination of cagrilintide 2.4 mg, a long-acting amylin analogue, and semaglutide 2.4 mg, the GLP-1 receptor agonist already approved…